Oramed Pharma(ORMP.US)

Last Updated 19:00:00 ET
longbridge loading

ORAMED PHARMACEUTICALS INC. 1Q 2026: Revenue $0 Net income $38.31M, EPS $0.91— 10-Q Summary

TradingView·
US
ORMP
-1.15%
US
IHI
+1.23%
US
XHE
+2.17%
TradingView·
US
ORMP
-1.15%
US
IHI
+1.23%
US
XHE
+2.17%

Oramed Pharmaceuticals And Two Other Promising Penny Stocks For Savvy Investors

Simplywall·
US
ORMP
-1.15%
US
LFMD
-0.93%
US
CERS
-0.37%
Simplywall·
US
ORMP
-1.15%
US
LFMD
-0.93%
US
CERS
-0.37%

Oramed Pharmaceuticals 2025 10-K: $2.0M Revenue, $1.50 Diluted EPS

TradingView·
US
ORMP
-1.15%
TradingView·
US
ORMP
-1.15%

Oramed Pharma | 10-K: FY2025 Revenue: USD 2 M

Earnings Watch·
US
ORMP
-1.15%
Earnings Watch·
US
ORMP
-1.15%

Lifeward Successfully Closes on Strategic Partnership with Oramed | LFWD Stock News

StockTitan·
US
IHI
+1.23%
US
ORMP
-1.15%
US
XHE
+2.17%
StockTitan·
US
IHI
+1.23%
US
ORMP
-1.15%
US
XHE
+2.17%

12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga_article·
US
PTH
+3.94%
US
BBH
+0.96%
US
AIFF
+1.20%
benzinga_article·
US
PTH
+3.94%
US
BBH
+0.96%
US
AIFF
+1.20%

Lifeward Shareholders Approve Oratech Deal and Governance Changes

Tip Ranks·
US
IHI
+1.23%
US
XHE
+2.17%
US
LFWD
+1.41%
Tip Ranks·
US
IHI
+1.23%
US
XHE
+2.17%
US
LFWD
+1.41%

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Price Passes Above 50 Day Moving Average - Here's Why

Market Beat·
US
ORMP
-1.15%
Market Beat·
US
ORMP
-1.15%

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Short Interest Up 57.8% in January

Market Beat·
US
ORMP
-1.15%
Market Beat·
US
ORMP
-1.15%
© 2026 Longbridge｜Disclaimer